The estimated Net Worth of John R Letcher is at least $5.12 Milion dollars as of 10 March 2014. John Letcher owns over 41,000 units of Revvity stock worth over $5,120,490 and over the last 15 years John sold PKI stock worth over $0.
John has made over 3 trades of the Revvity stock since 2012, according to the Form 4 filled with the SEC. Most recently John exercised 41,000 units of PKI stock worth $724,060 on 10 March 2014.
The largest trade John's ever made was exercising 41,000 units of Revvity stock on 10 March 2014 worth over $724,060. On average, John trades about 4,429 units every 39 days since 2010. As of 10 March 2014 John still owns at least 44,414 units of Revvity stock.
You can see the complete history of John Letcher stock trades at the bottom of the page.
John's mailing address filed with the SEC is 940, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe oraz Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: